2 Results

People

  1. Dang
    Dang
  2. Hudis
    Hudis
  3. Rizvi
    Rizvi
  4. Rudin
    Rudin

Groups

  1. Department of Medicine (2)
  2. Solid Tumor Oncology Division (2)
  3. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  4. Breast Medicine Service (1)
  5. GSK Faculty (1)
  6. Survivorship Research (1)
  7. Thoracic Oncology (1)
  1. "safety"
  2. "Journal article"
  3. "Massachusetts Medical Society"
Formats
  1. Journal Article (2)
Groups
  1. Department of Medicine (2)
  2. Solid Tumor Oncology Division (2)
  3. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  4. Breast Medicine Service (1)
  5. GSK Faculty (1)
  6. Survivorship Research (1)

More Groups

People
  1. Charles Rudin (1)
  2. Chau Dang (1)
  3. Clifford Hudis (1)
  4. Naiyer Rizvi (1)
Years
  1. 2015 (2)
Publications
  1. New England Journal of Medicine (2)
Publishers
  1. Massachusetts Medical Society (2)

Results (2)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
    Journal Article

    Borghaei, H.; Paz-Ares, L.; Horn, L.; Spigel, D. R.; Steins, M.; Ready, N. E.; Chow, L. Q.; Vokes, E. E.; Felip, E.; Holgado, E.; more...
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save
  • Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer
    Journal Article

    Tolaney, S. M.; Barry, W. T.; Dang, C. T.; Yardley, D. A.; Moy, B.; Marcom, P. K.; Albain, K. S.; Rugo, H. S.; Ellis, M.; Shapira, I.; more...
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save